Clinical Trial Update: Neoadjuvant Serplulimab in Combination With Chemotherapy in Locally Advanced Gastric or Gastro-esophageal Junction Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial is evaluating neoadjuvant serplulimab with chemotherapy for locally advanced gastric or gastroesophageal junction cancer. Recruitment is ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Gastric Adenocarcinoma | Phase 2 | Status: RECRUITING